Caliskan Cemil, Guler Necdet, Karaca Can, Makay Ozer, Firat Ozgur, Korkut Mustafa A
Department of General Surgery/Division of Proctology, School of Medicine, Ege University, Turkey Izmir.
Indian J Surg. 2010 Jun;72(3):243-8. doi: 10.1007/s12262-010-0052-1. Epub 2010 Aug 26.
Colorectal carcinoma (CRC) is the most frequent malignancy of the gastrointestinal tract. Prognostic researches are carried out for choosing the optimum therapy, evaluating therapy results and comparing multicentre results for better qualification in the therapy of the disease.
In this study, 448 patients, whose surgery and follow-up was performed by the same correspondent surgeon between the years 1995 and 2003, were retrospectively analyzed.
Age, presence of comorbidity, weight loss, emergency admission, high serum CEA and CA 19-9 levels, neighboring organ invasion, operation type, major morbidity, tumor size and type, lymph node metastases, venous and perineural invasion, Dukes' classification and local recurrence and distant metastasis during follow-up are found to be significant negative factors affecting prognosis of the CRC patient.
Therapy results of the CRC are evaluated by survival times regardless of the therapy method selected for each individual. In our study we tried to find out negative prognostic factors by researching possible factors affecting disease free survival time for CRC. Since our understanding of factors that have an impact on prognosis increases, we are hoping to improve survival.
结直肠癌(CRC)是胃肠道最常见的恶性肿瘤。开展预后研究有助于选择最佳治疗方案、评估治疗效果以及比较多中心研究结果,从而提高该病的治疗水平。
本研究对1995年至2003年间由同一位外科医生进行手术及随访的448例患者进行了回顾性分析。
年龄、合并症情况、体重减轻、急诊入院、血清癌胚抗原(CEA)和糖类抗原19-9(CA 19-9)水平升高、邻近器官侵犯、手术类型、主要并发症、肿瘤大小和类型、淋巴结转移、静脉和神经周围侵犯、Dukes分期以及随访期间的局部复发和远处转移均被发现是影响CRC患者预后的显著负面因素。
无论为每个患者选择何种治疗方法,均通过生存时间来评估CRC的治疗效果。在本研究中,我们试图通过研究影响CRC无病生存时间的可能因素来找出负面预后因素。随着我们对影响预后因素的认识不断提高,我们希望能改善患者的生存状况。